Treatment.com AI Stock Price, News & Analysis

Treatment.com AI (TREIF) has signed a Collaborative Agreement with Beijing Aiyi Botong Information Technology (Aiyibotong) to explore commercial opportunities for Clinical Decision Support Systems (CDSS) in China and Far East markets. The partnership aims to combine Treatment's Global Library of Medicine (GLM) with Aiyibotong's CDSS technology.

Key highlights:

• China's CDSS market expected to reach ~US$600 million by 2030
• Aiyibotong has installations in over 200 healthcare institutions in China
• Digital Health investment in China projected to hit US$45 billion in 2025

The collaboration includes GLM content localization, technology licensing, co-marketing initiatives, and joint development of AI-based CDSS for the global market. The agreement was signed on February 19, 2025, with no associated costs.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announces significant growth of Rocket Doctor's virtual healthcare platform in Alberta. The platform has served over 71,000 Albertans, with 35% from communities under 25,000 population.

Key achievements include:

• 112% increase in patient visits year-over-year, serving 36,779 patients
• 218% growth in new physicians joining the platform, with 48 new doctors onboard
• 4.4-star Google rating from over 2,400 reviews

Rocket Doctor's model enables independent physicians to operate efficiently while covered under Alberta's provincial health insurance. The company plans to integrate AI-driven tools and expand its services across Canada. Treatment.com AI Inc. has a definitive share purchase agreement dated February 11, 2025, to acquire Rocket Doctor Inc.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announces significant growth of Rocket Doctor in Alberta, showcasing impressive metrics in healthcare accessibility. The virtual healthcare marketplace has served over 71,000 Albertans, with 35% from communities under 25,000 population.

Key achievements include a 112% year-over-year increase in patient visits, totaling 36,779 patients, and a remarkable 218% growth in new physicians joining the platform. The platform maintains a strong 4.4-star rating on Google with over 2,400 reviews.

Rocket Doctor's unique model supports independent doctors with technology and administrative support, covered under Alberta's provincial health insurance. The company is focused on expanding its physician network and integrating AI-driven tools to improve healthcare accessibility across the province.

Treatment.com AI Inc. (OTC: TREIF) has successfully closed its upsized brokered private placement, raising $3.3 million through the issuance of 6,600,000 units at $0.50 per unit. Each unit includes one common share and half a share purchase warrant, with warrants exercisable at $0.75 until March 13, 2027.

The company paid the underwriter, Ventum Capital Corp., a cash commission of $264,000 and issued 528,000 non-transferable broker warrants. The proceeds will be allocated to sales and administrative expenses, software research and development, and working capital purposes.

Treatment.com AI specializes in healthcare AI technology, having developed the Global Library of Medicine (GLM), an AI engine built with input from hundreds of healthcare professionals. The GLM platform provides clinical information, recommended tests, and billing codes to healthcare professionals, aiming to reduce administrative burden and improve patient care quality.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) has announced that Rocket Doctor has been approved as an in-network provider for New York Medicaid, giving 6.9 million beneficiaries (35% of the state's population) access to virtual healthcare services.

Starting January 22, 2025, Rocket Doctor's board-certified physicians will offer primary, urgent, and specialty care to Medicaid recipients through its telehealth platform, with accreditation valid until 2030. This initiative aims to reduce ER visits, decrease wait times, and improve access to timely specialist referrals.

Additionally, Rocket Doctor is collaborating with EngageWell, a network of health and human service organizations serving low-income populations in New York City. This partnership, supported by a US$1 million grant, will enhance virtual care for aging New Yorkers through telehealth, remote patient monitoring, and addressing social determinants of health.

Clients served by any EngageWell provider can now book virtual consultations with Rocket Doctor's network of physicians across more than 20 specialties, aiming to streamline access to outpatient care and improve healthcare outcomes while reducing costs.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announced that Rocket Doctor has been approved as an in-network provider for New York Medicaid, giving 6.9 million beneficiaries (35% of the state's population) access to virtual healthcare services. Starting January 22, 2025, Rocket Doctor's board-certified physicians will offer primary, urgent, and specialty care through their telehealth platform, with accreditation valid until 2030.

Additionally, Rocket Doctor is collaborating with EngageWell, a network of health and human service organizations serving low-income populations in New York City. This partnership, supported by a US$1 million grant, aims to enhance virtual care for aging New Yorkers through telehealth, remote patient monitoring, and addressing social determinants of health.

The initiative is designed to reduce ER visits, decrease wait times, and improve access to timely specialist referrals, particularly for underserved communities who can now receive care from home.

Treatment.com AI has announced the release of its updated Medical Education Suite (MES), coinciding with their participation in the AI Assessment Symposium at the University of Minnesota Medical School. The enhanced MES platform aims to support OSCE exams, taken by 200,000-300,000 medical students globally each year. New features include AI Patient for exam preparation, expanded OSCE Case Packages, and an AI Prep Tool with guided and non-guided learning options. The company plans further developments including AI Doctor in a Pocket and Audio/Video Analysis capabilities through 2024 and early 2025.

Treatment.com AI has launched an updated Medical Education Suite (MES) coinciding with their participation in the AI Assessment Symposium at the University of Minnesota Medical School. The enhanced platform aims to support OSCE exams, taken by 200,000-300,000 medical students globally annually. New features include AI Patient for exam preparation, expanded OSCE Case Packages planned for up to 100 cases through Q4 2024, and an AI Prep Tool with guided and non-guided learning support. Future developments include AI Doctor in a Pocket and Audio/Video Analysis capabilities.

Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) announces its participation in the 2024 Cantech Letter Investment Conference on October 9, 2024 in Toronto, Ontario. CEO Dr. Essam Hamza will deliver an investor presentation at 11:00 AM ET and participate in 1-on-1 meetings with investors. The event will take place at the Arcadian Loft, 8th floor, 401 Bay Street.

Dr. Hamza emphasized the conference's importance, stating, "The healthcare system is at the precipice of substantial modernization and we believe that our proprietary platform can help with reducing its inefficiencies, reducing administration headaches, and ultimately improving patient access and care." Interested parties can contact tara@cantechletter.com to register or schedule 1-on-1 meetings with Treatment.com AI.